InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Beyer Russell P, Chief Financial Officer. Director active across 1 company, notably SAB Biotherapeutics, Inc.. In total, 1 filings have been logged. Activity tracked since 18 October 2021. The latest transaction was filed on 18 October 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Russell P. Beyer is the Chief Financial Officer at SAB Biotherapeutics, Inc. He oversees the financial operations of the company, including budgeting and financial reporting. His role is essential in ensuring the financial health and growth of SAB Biotherapeutics.